Article | 2020.08.13
The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...
Vidéo | 2025.04.04
Meningitis: warning signs!200 cases in France since January? Yes, but... This figure concerns invasive meningococcal infections, a 25-year record. But not all of them are meningitis!Dr Samy Taha, medical researcher at the CNR des Méningocoques, reminds us of the importance of prevention and rapid screening to limit serious forms of the disease.Symptoms to watch out for :High fever and intense...
Vidéo | 2025.04.07
Measles explodes in 2025: what do we do?Nearly 200 cases in France this year, twice as many as last year! This ultra-contagious virus infects the respiratory tract before spreading throughout the body. 1 patient can infect 20 - as easily as a cold! Fever, cough, rash... but above all serious complications for 1 in 5 people: pneumonia, encephalitis, hospitalization, and babies at risk. Over a...
Article | 2025.02.27
Through a partnership between Ludwig Maximilian University (LMU) of Munich and the Institut Pasteur, outstanding medical students can pursue hands-on research in Paris. This unique framework, part of the Institut Pasteur MD-PhD program and the LMU StEP program, enriches clinical training with cutting-edge biomedical research.
News | 2017.05.02
The Search Committee for Director of the Institut Pasteur invites expressions of interest from potential candidates for the position of Director of the Institute. The Search Committee for Director of the Institut Pasteur welcomes letters of interest accompanied by curriculum vitae. Please send all letters and other inquiries by e-mail to searchcommittee2017@pasteur.fr. All...
News | 2017.06.29
WHO adopted in 2016 a global strategy to eliminate hepatitis B and C by 2030. On the basis of anthropological analyses conducted in multiple African countries, a group of researchers, including some from the Institut Pasteur, suggest that to achieve these goals it is essential to improve the communication about viral hepatitis. According to WHO, viral hepatitis caused 1.34 million deaths in...
News | 2017.07.06
The documentary Unseen Enemy (with French subtitles), a film about our vulnerability to global epidemics, will be streaming on ARTE.TV, in France and Germany, between July 5th and July 26th. This film has been directed and co-produced by Emmy award-winning filmmaker Janet Tobias, with numerous partners and allies, in particular the Institut Pasteur. “What is it about the 21st century that...
Article | 2019.05.21
Ever since its very early days, the Institut Pasteur has been committed to tackling emerging infections, and its work has left an extraordinary legacy. Many emerging infectious diseases are zoonoses, in which an animal pathogen has crossed the species barrier to cause disease in humans.
Article | 2019.05.21
Antimicrobial resistance is dramatically increasing worldwide and is becoming one of the most urgent public health threats. There is an urgent need for actions to reverse the curve of antimicrobial resistance dissemination and to develop innovative drugs (antibiotics, antiparasitic, antifungals, antivirals, antivectors) and therapeutic strategies for safer and sustainable treatments of infectious...
Article | 2019.05.21
The Institut Pasteur has installed a research program to leverage the wide-ranging basic research expertise in the fields of neuroscience, genetics, cell and developmental biology, immunology, microbiology and infection biology to improve the understanding of the complexity of brain function and its associated disorders.